[The possibility of the circulation of vaccinal influenza A viral strains in the biosphere].

PubWeight™: 0.75‹?›

🔗 View Article (PMID 2097126)

Published in Dokl Akad Nauk SSSR on January 01, 1990

Authors

N A Petrov, O I Kiselev, E B Grinbaum, T Ia Luzianina, F I Polezhaev, S K Vasilenko

Articles by these authors

[Isolation of highly purified ribonuclease from cobra (Naja oxiana) venom]. Biokhimiia (1976) 2.80

A method for DNA sequencing by hybridization with oligonucleotide matrix. DNA Seq (1991) 2.70

The genomic sequence analysis of the left and right species-specific terminal region of a cowpox virus strain reveals unique sequences and a cluster of intact ORFs for immunomodulatory and host range proteins. Virology (1998) 1.44

[Serological and epidemological data on associated vaccines against measles and mumps]. Tr Leningr Nauchnoissled Inst Epidemiol Mikrobiol (1965) 1.40

Human monkeypox and smallpox viruses: genomic comparison. FEBS Lett (2001) 1.32

Analysis of the monkeypox virus genome. Virology (2002) 1.27

[Isolation and properties of ribonuclease isolated from cobra venom]. Biokhimiia (1966) 1.16

[Synthesis of a full-length DNA copy of the hemagglutinin gene of the the influenza virus A H1N1 subtype, its cloning and primary structure]. Bioorg Khim (1984) 1.02

Study of live recombinant cold-adapted influenza bivalent vaccine of type A for use in children: an epidemiological control trial. Vaccine (1986) 1.01

Analysis of genome composition and reactogenicity of recombinants of cold-adapted and virulent virus strains. J Gen Virol (1981) 0.98

A rightward promoter to the left of the att site of lambda phage DNA: possible participant in site-specific recombination. Gene (1979) 0.96

[Molecular weight distribution of hydrolysis products of polyuridylic acid by cobra venom ribonuclease. Preparation of polynucleotides of required molecular weight]. Biokhimiia (1978) 0.95

Recombinant cold-adapted attenuated influenza A vaccines for use in children: reactogenicity and antigenic activity of cold-adapted recombinants and analysis of isolates from the vaccinees. Infect Immun (1984) 0.94

DNA-polycation complexes: effect of polycation structure on physico-chemical and biological properties. J Biotechnol (2006) 0.94

Recombinant cold-adapted attenuated influenza A vaccines for use in children: molecular genetic analysis of the cold-adapted donor and recombinants. Infect Immun (1984) 0.93

[Isolation of temperature-sensitive strains of the influenza virus in the epidemic caused by the A/Victoria virus in 1975-1976]. Vopr Virusol (1979) 0.91

[Primary structure of the full-size DNA copy of the influenza virus A/Kiev/59/79 (H1N1) PB1 gene protein]. Bioorg Khim (1987) 0.90

Amyloidogenic peptide homologous to beta-domain region of alpha-lactalbumin. Dokl Biochem Biophys (2007) 0.89

Plant-produced recombinant influenza vaccine based on virus-like HBc particles carrying an extracellular domain of M2 protein. Biochemistry (Mosc) (2012) 0.88

Effect of base analog substitutions in the specific GATC site on binding and methylation of oligonucleotide duplexes by the bacteriophage T4 Dam DNA-[N6-adenine] methyltransferase. Nucleic Acids Res (1999) 0.87

Conditions for production of thermosensitive attenuated influenza virus recombinants. Acta Virol (1978) 0.87

Peculiarities of obtaining attenuated thermosensitive recombinants of influenza A virus at the end of the H3N2 epidemic cycle. Acta Virol (1980) 0.86

Attenuated ts-recombinants of influenza A/USSR/77 (H1N1) virus obtained by crossing with the cold-adapted donor A/Leningrad/134/57 (H2N2) virus. Acta Virol (1982) 0.86

[Primary structure of the DNA copy of the protein VP1 gene of the foot-and-mouth disease virus A22]. Bioorg Khim (1986) 0.85

Interaction of the phage T4 Dam DNA-[N6-adenine] methyltransferase with oligonucleotides containing native or modified (defective) recognition sites. Nucleic Acids Res (1997) 0.85

Vaccine potential of influenza vectors expressing Mycobacterium tuberculosis ESAT-6 protein. Tuberculosis (Edinb) (2006) 0.84

[Hybridization of DNA with oligonucleotides immobilized in a gel: a convenient method for recording single base replacements]. Mol Biol (Mosk) (1991) 0.84

[The primary structure of the hemagglutinin of influenza A (H3N2) viruses isolated in the USSR in 1985]. Vopr Virusol (1989) 0.83

[Analysis of pandemic influenza in Russia as a part of the global process based on data of an influenza monitoring reference center]. Zh Mikrobiol Epidemiol Immunobiol (2011) 0.83

Amplification of DNA sequences of Epstein-Barr and human immunodeficiency viruses using DNA-polymerase from Thermus thermophilus. Mol Cell Probes (1990) 0.82

Results of virological and serological studies of three influenza A Hong-Kong epidemics in Leningrad. J Hyg Epidemiol Microbiol Immunol (1976) 0.82

Multiple genetic differences between the monkeypox and variola viruses. Dokl Biochem Biophys (2002) 0.82

Results of virological and serological studies of three influenza A Hong-Kong epidemics in Leningrad. J Hyg Epidemiol Microbiol Immunol (1976) 0.82

[Cowpea mosaic virus chimeric particles bearing ectodomain of matrix protein 2 (M2E) of influenza A virus: production and characteristics]. Mol Biol (Mosk) (2009) 0.81

[The 2009 pandemic influenza in Russia. I. Diagnosis and molecular biological characteristics of the virus]. Vopr Virusol (2011) 0.81

Atomic force microscopy study of peptides homologous to beta-domain of alpha-lactalbumins. Protein Pept Lett (2007) 0.81

[Preparatory extraction of 5'-oligoribonucleotides using ribonuclease from cobra venom]. Biokhimiia (1976) 0.81

[Antiviral activity of several vasodilator agents]. Biull Eksp Biol Med (1996) 0.81

Recombinant influenza vaccines. Acta Naturae (2012) 0.80

[Synthesis, cloning and determination of the primary structure of a full-size DNA copy of the neuraminidase gene from influenza virus type A subtype H1N1]. Bioorg Khim (1985) 0.80

[Synthesis, cloning and determination of the primary structure of a full-size DNA copy of fragment 8 from the influenza virus type A genome]. Bioorg Khim (1985) 0.80

DNA sequencing with thermostable Tet DNA polymerase from Thermus thermophilus. Nucleic Acids Res (1989) 0.80

Nucleotide sequence of the Galleria mellonella nuclear polyhedrosis virus origin of DNA replication. FEBS Lett (1984) 0.80

The efficacy of cell therapy in the treatment of patients with trophic venous ulcers of the lower limbs. Angiol Sosud Khir (2007) 0.79

Temperature-sensitive recombinants of influenzavirus B. Acta Virol (1978) 0.79

[Secondary structure of the M2 protein of influenza type A virus and its role in forming resistance to rimantadine and deitiforin]. Mol Biol (Mosk) (1995) 0.79

[Activation of free radicals reaction and changes in the state of antioxidant protection in blood in toxic experimental influenza infection]. Biull Eksp Biol Med (1992) 0.78

[Universal diagnostic oligonucleotide microarray for subtyping of human and animal influenza A viruses]. Vopr Virusol (2014) 0.78

[Molecular characteristic of influenza virus A H5N1 Strains isolated from poultry in Kurgan Region in 2005]. Mol Biol (Mosk) (2008) 0.78

[Primary structure of the full-size DNA copy of the hemagglutinin gene of influenza virus A/Kiev/59/79 (H1N1)]. Bioorg Khim (1986) 0.78

[Effect of different water-soluble forms of the fullerene C60 on the metabolic activity and ultra-structure of cells in culture]. Biofizika (2012) 0.77

[Study of tolerability and reactogenicity of pandemic vaccines against influenza type A/H1N1]. Zh Mikrobiol Epidemiol Immunobiol (2010) 0.77

[Protective activity of Ingavirin in experimental lethal influenza due to pandemic influenza virus A (H1N1)v in albino mice]. Antibiot Khimioter (2010) 0.77

[Antiviral activity of Ingavirin in experimental lethal influenza due to influenza virus B in albino mice]. Antibiot Khimioter (2010) 0.77

[Experimental study of Ingavirin antiviral activity against human adenovirus]. Antibiot Khimioter (2010) 0.77

[In vitro and in vivo effects of ingavirin on the ultrastructure and infectivity of influenza virus]. Vopr Virusol (2011) 0.77

[Specificity of synthetic polyribonucleotides hydrolysis by endoribonuclease from cobra (Naja oxiana) venom]. Biokhimiia (1981) 0.77

Fatty acid acylated antibodies against virus suppress its reproduction in cells. FEBS Lett (1989) 0.77

Development of Recombinant Vaccine against A(H1N1) 2009 Influenza Based on Virus-like Nanoparticles Carrying the Extracellular Domain of M2 Protein. Acta Naturae (2010) 0.77

[Reconstruction of autonomic genetic and protein-synthesizing systems from viral RNA and isolated mitochondria]. Dokl Akad Nauk SSSR (1971) 0.76

[The structural and functional analysis of the biological activity of acridine derivatives]. Vestn Ross Akad Med Nauk (2004) 0.76

[Experimental investigation of Ingavirin antiviral activity against human parainfluenza virus]. Antibiot Khimioter (2010) 0.76

[Development of the anti-influenza H5N1 vaccines worldwide and in Russia]. Zh Mikrobiol Epidemiol Immunobiol (2006) 0.76

Primary structure of the gene coding for the haemagglutinin of influenza virus A/Leningrad/385/80(H3N2): detection of a point mutation responsible for the antigenic drift. Acta Virol (1990) 0.76

Antigenic profile of neuraminidases of influenza A viruses isolated in 1957-1973. Acta Virol (1974) 0.76

[Universal influenza vaccines: developments, prospects for use]. Vopr Virusol (2012) 0.76

Insulin fibrillogenesis in vitro. Dokl Biochem Biophys (2008) 0.76

[Reactogenicity, genetic stability and effectiveness of a live recombinant influenza vaccine for children designed on the base of a cold-adapted attenuation donor A/Leningrad/134/47/57]. Vopr Virusol (1986) 0.76

[Serological foundation for the persisting circulation of influenza viruses A(HON1) and A(H2N2) among children]. Vopr Virusol (1983) 0.75

[Influence of rimantadine, ribavirine and triazavirine on influenza A virus replication in human monolayer and lymphoblastoid cell lines]. Antibiot Khimioter (2011) 0.75

[Antiviral action of some antioxidants/antihypoxants and their combinations with remantadine against human influenza A(H3N2) virus studied in in vitro models]. Eksp Klin Farmakol (2007) 0.75

[Use of an RNAse inhibitor from the human placenta in specific fragmentation of high molecular weight RNA by ribonuclease H]. Bioorg Khim (1985) 0.75

[The results of using the molecular hybridization of nucleic acids in the complex study of nasopharyngeal smears from patients with influenza and other acute respiratory diseases]. Zh Mikrobiol Epidemiol Immunobiol (1990) 0.75

[Toxic action of influenza virus on lymphoid-macrophagal reactions in guinea pigs]. Biull Eksp Biol Med (1976) 0.75

[Compatibility of mitochondrial ribosomes with matrix RNA of nuclear origin]. Dokl Akad Nauk SSSR (1973) 0.75

[Primary structure of a full-size DNA copy of the influenza virus A/Kiev/59/79 (H1N1) neuraminidase gene]. Bioorg Khim (1985) 0.75

[Structure and function of matrix RNAs in living cells]. Usp Sovrem Biol (1975) 0.75

[Determination of nucleotide sequences in oligonucleotides]. Dokl Akad Nauk SSSR (1965) 0.75

[Integration of the synthesis of mitochondrial proteins in the system of cytoplasmic and mitochondrial polyribosomes]. Dokl Akad Nauk SSSR (1974) 0.75

[Gene expression of the surface antigen of the hepatitis B virus in yeast cells]. Mol Gen Mikrobiol Virusol (1986) 0.75

[Basis of the anthroponotic nature of human pandemic influenza A viruses]. Vopr Virusol (1981) 0.75

[Primary structure of the full-size DNA copy of the NP gene of influenza virus A/Kiev/59/79 (H1N1)]. Bioorg Khim (1986) 0.75

[The determination of the genotype of natural reassortant influenza A viruses according to the core protein genes by the methods of competitive dot hybridization and sequencing]. Vopr Virusol (1993) 0.75

[The genome structure of influenza virus A/Leningrad/23/81/(H1N1)]. Mol Gen Mikrobiol Virusol (1990) 0.75

[Features of interepidemic influenza A and B viruses]. Vestn Ross Akad Med Nauk (1995) 0.75

[Effect of homologous nuclear RNA and infectious RNA of the Venezuelan equine encephalitis virus on the biosynthesis of RNA and protein in isolated rat liver mitochondria]. Biokhimiia (1974) 0.75

[Synthesis, cloning and determination of the primary structure of a full-size DNA copy of the NP protein gene from influenza virus type A]. Bioorg Khim (1985) 0.75

[Structural rearrangements in influenza virus hemagglutinin during crossing the inter-species barrier]. Dokl Akad Nauk SSSR (1986) 0.75

[The nucleotide sequence of the 3'-terminal region of encephalomyocarditis virus RNA]. Bioorg Khim (1983) 0.75

[Nucleotide sequence of the hemagglutinin gene of the influenza virus A/Udorn/307/72 (H3N2)]. Dokl Akad Nauk SSSR (1984) 0.75

[Int-protein lambda phage DNA binding site is situated to the right of the att-site]. Dokl Akad Nauk SSSR (1980) 0.75

[Antigenic relations between neuraminidases N 1 of human influenza viruses type A]. Virologie (1981) 0.75

[The primary structure of the hemagglutinin gene of strain A/Riga/9977/86--a drift variant of influenza virus A(H3N2)]. Vopr Virusol (1991) 0.75

[Primary structure of the hemagglutinin gene in strains of the influenza virus A/Leningrad/624/86 and A/Leningrad/621/86 serologic subtype H1N1]. Vopr Virusol (1991) 0.75

[Specificity of the nuclease from the venom of the Middle Asia cobra (Naja naja oxiana) to the macrostructure of polyribonucleotides]. Mol Biol (Mosk) (1983) 0.75

[Improvements in the classification and nomenclature of the influenza A viruses]. Vopr Virusol (1982) 0.75